Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dodwell

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Breast Cancer Research : BCR|October 25, 2011
Male breast carcinoma: increased awareness neededJonathan White, Olive Kearins, David Dodwell, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 18, 2025
The Impact of Body Mass Index (BMI) on Clinical Outcomes for Patients Receiving Systemic Anti-Cancer Therapies for Advanced Clear Cell Renal CarcinomaJohn Greene, Zhe Wang, Benjamin H L Harris, et al.
BMJ (Clinical Research Ed.)|December 2, 2020
Treatment variation in early breast cancer in the UKDavid Dodwell, Yasmin Jauhari, Toral Gathani, et al.
BMJ (Clinical Research Ed.)|January 24, 2024
Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort studyGurdeep S Mannu, Zhe Wang, David Dodwell, et al.
Journal of Bone Oncology|December 14, 2017
Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer - An AZURE (BIG 01/04) sub-studyCaroline Wilson, Samantha Hinsley, Helen Marshall, et al.
The Journal of Pathology. Clinical Research|September 18, 2025
Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988-2016Jake Probert, John Broggio, Sarah C Darby, et al.
The British Journal of Surgery|December 14, 2021
Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: a population-based study in EnglandToral Gathani, Gillian Reeves, David Dodwell, et al.
Cancer Epidemiology|May 26, 2019
Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration dataGabrielle Emanuel, Katherine E Henson, John Broggio, et al.
The Lancet. Oncology|March 9, 2004
Oestrogen receptor beta: what it means for patients with breast cancerValerie Speirs, Pauline J Carder, Sally Lane, et al.
Cancer Epidemiology|March 27, 2025
The impact of the COVID-19 pandemic on the use of systemic therapy for patients diagnosed with cancer in England: A population-based study with a focus on breast and lung cancerLaura Webster, Sarah Lawton, Katherine Thackray, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Breast Cancer Research : BCR|October 25, 2011
Male breast carcinoma: increased awareness neededJonathan White, Olive Kearins, David Dodwell, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 18, 2025
The Impact of Body Mass Index (BMI) on Clinical Outcomes for Patients Receiving Systemic Anti-Cancer Therapies for Advanced Clear Cell Renal CarcinomaJohn Greene, Zhe Wang, Benjamin H L Harris, et al.
BMJ (Clinical Research Ed.)|December 2, 2020
Treatment variation in early breast cancer in the UKDavid Dodwell, Yasmin Jauhari, Toral Gathani, et al.
BMJ (Clinical Research Ed.)|January 24, 2024
Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort studyGurdeep S Mannu, Zhe Wang, David Dodwell, et al.
Journal of Bone Oncology|December 14, 2017
Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer - An AZURE (BIG 01/04) sub-studyCaroline Wilson, Samantha Hinsley, Helen Marshall, et al.
The Journal of Pathology. Clinical Research|September 18, 2025
Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988-2016Jake Probert, John Broggio, Sarah C Darby, et al.
The British Journal of Surgery|December 14, 2021
Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: a population-based study in EnglandToral Gathani, Gillian Reeves, David Dodwell, et al.
Cancer Epidemiology|May 26, 2019
Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration dataGabrielle Emanuel, Katherine E Henson, John Broggio, et al.
The Lancet. Oncology|March 9, 2004
Oestrogen receptor beta: what it means for patients with breast cancerValerie Speirs, Pauline J Carder, Sally Lane, et al.
Cancer Epidemiology|March 27, 2025
The impact of the COVID-19 pandemic on the use of systemic therapy for patients diagnosed with cancer in England: A population-based study with a focus on breast and lung cancerLaura Webster, Sarah Lawton, Katherine Thackray, et al.
Pageof 12